Osteoarthritis (OA) is the leading cause of joint pain and disability in middle-aged and elderly patients, and is characterized by progressive loss of articular cartilage. Among the various matrix metalloproteinases (MMPs), MMP-13 is specifically expressed in the cartilage of human OA patients and is not present in normal adult cartilage. Thus, MMP-13-selective inhibitors are promising candidates in osteoarthritis therapy. Recently, we designed an N-isopropoxy-arylsulfonamide-based hydroxamat...Expand abstract
- Publisher copy:
- Copyright date:
Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record